Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.15 USD | -0.47% | +1.87% | -22.94% |
15/05 | Legend Expects to Log Profit in 2026 | MT |
14/05 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.94% | 8.45B | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.44% | 22.28B | |
-5.61% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- JPMorgan Adjusts Price Target on Legend Biotech to $76 From $65, Maintains Overweight Rating